These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 15355738

  • 1. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J, Urban M, Urban B, Głowińska B, Florys B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [Abstract] [Full Text] [Related]

  • 2. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J, Urban M, Głowińska B, Urban B.
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [Abstract] [Full Text] [Related]

  • 3. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH.
    Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
    [Abstract] [Full Text] [Related]

  • 4. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus.
    Acerini CL, Clayton KL, Hintz R, Baker B, Watts A, Holly JM, Dunger DB.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133
    [Abstract] [Full Text] [Related]

  • 5. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys.
    Zachrisson I, Brismar K, Carlsson-Skwirut C, Dahlquist G, Wallensteen M, Bang P.
    Growth Horm IGF Res; 2000 Dec; 10(6):324-31. PubMed ID: 11161963
    [Abstract] [Full Text] [Related]

  • 6. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
    Amin R, Williams RM, Frystyk J, Umpleby M, Matthews D, Orskov H, Dalton RN, Dunger DB.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188
    [Abstract] [Full Text] [Related]

  • 7. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B, Kural N, Colak O, Ak I, Akcar N.
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
    [Abstract] [Full Text] [Related]

  • 8. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ.
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [Abstract] [Full Text] [Related]

  • 9. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ, Luo SM, Hu WJ.
    Zhonghua Wai Ke Za Zhi; 2005 Jun 01; 43(11):697-701. PubMed ID: 16008955
    [Abstract] [Full Text] [Related]

  • 10. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
    Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F.
    Eur Cytokine Netw; 2006 Sep 01; 17(3):167-74. PubMed ID: 17194636
    [Abstract] [Full Text] [Related]

  • 11. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
    Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z.
    Cas Lek Cesk; 2001 Apr 26; 140(8):234-7. PubMed ID: 11392040
    [Abstract] [Full Text] [Related]

  • 12. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC, Kilic Z, Buyukkaragoz B, Ucar B, Alatas O, Aydogdu SD, Dogruel N.
    Neuro Endocrinol Lett; 2007 Jun 26; 28(3):279-83. PubMed ID: 17627262
    [Abstract] [Full Text] [Related]

  • 13. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.
    Clin Endocrinol (Oxf); 2006 Oct 26; 65(4):439-45. PubMed ID: 16984235
    [Abstract] [Full Text] [Related]

  • 14. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.
    Ekström K, Salemyr J, Zachrisson I, Carlsson-Skwirut C, Ortqvist E, Bang P.
    Diabetes Care; 2007 Jun 26; 30(6):1357-63. PubMed ID: 17372150
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus.
    Malamitsi-Puchner A, Sarandakou A, Tziotis J, Dafogianni C, Bartsocas CS.
    Pediatr Res; 1998 Dec 26; 44(6):873-5. PubMed ID: 9853920
    [Abstract] [Full Text] [Related]

  • 16. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun 26; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 17. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
    Loukovaara S, Immonen IJ, Koistinen R, Rutanen EM, Hiilesmaa V, Loukovaara M, Kaaja RJ.
    J Diabetes Complications; 2005 Jun 26; 19(5):297-304. PubMed ID: 16112506
    [Abstract] [Full Text] [Related]

  • 18. Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients.
    Lunetta M, Di Mauro M, Le Moli R, Nicoletti F.
    Diabetes Metab; 1997 Dec 26; 23(6):524-7. PubMed ID: 9496559
    [Abstract] [Full Text] [Related]

  • 19. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep 26; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 20. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH, Wildschiødtz G, Juul A, Hilsted J.
    Obesity (Silver Spring); 2008 Jul 26; 16(7):1516-21. PubMed ID: 18464752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.